Association of Pro12Ala (rs1801282) variant of PPAR gamma with Rheumatoid Arthritis in a Pakistani population

References

Page 1

	Year	Citations
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Frank C. Arnett, Steven M. Edworthy, D. Blöch, Arthritis & Rheumatism	1988	19.8K
Revised Criteria for the Classification of Rheumatoid Arthritis Frank C. Arnett Orthopaedic Nursing Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesClassification Criteria	1990	7.7K
A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Samir S. Deeb, Lluís Fajas, Masami Nemoto, Nature Genetics Insulin ResistanceMetabolic SyndromeMolecular PharmacologyInsulin SensitivityBody Composition	1998	1.3K
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Alex J. MacGregor, Harold Snieder, Alan S. Rigby, Arthritis & Rheumatism	2000	1.2K
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response Chinyu Su, Xiaoming Wen, Shannon T. Bailey, Journal of Clinical Investigation	1999	751
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone Brent A. Neuschwander‐Tetri Hepatology PathologyPpar-γ Ligand RosiglitazonePharmacotherapyFatty Liver DiseaseGlucose Tolerance	2003	699
The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance Toshimasa Yamauchi, Junji Kamon, Hironori Waki, Journal of Biological Chemistry	2001	635
Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer Pierre Desreumaux, Laurent Dubuquoy, Sophie Nutten, The Journal of Experimental Medicine	2001	448
Peroxisome Proliferator-Activated Receptors Ernesto L. Schiffrin, Farhad Amiri, Karim Benkirane, Hypertension Lipid PeroxidationPharmacotherapyRedox BiologyBlood PressureOxidative Stress	2003	369
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes Kazuo Hara, Terumasa Okada, Kazuyuki Tobe, Biochemical and Biophysical Research Communications Insulin ResistanceMetabolic SyndromeGenetic DeterminantGeneticsPhysiology	2000	274

Page 1